Europe’s New AMR Surveillance Update: What the 2025 Data Can—and Cannot—Tell Us

Antimicrobial resistance is often discussed as a future danger, but the latest European surveillance update describes a problem that is already shaping everyday care. On 18 November 2026, the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe released an executive summary based on 2025 data from two coordinated surveillance networks.

What the new report covers

The analysis combines information on invasive bacterial isolates reported through EARS-Net, which covers 30 EU/EEA countries, and CAESAR, which received reports from 17 additional countries in the WHO European Region. These networks use compatible methods, allowing experts to track resistance patterns across a broad geographic area.

That does not mean every country can be ranked as if the data came from one identical laboratory system. The report explicitly notes that national surveillance programmes differ in sampling, clinical practice, laboratory capacity and reporting. A higher recorded percentage can reflect a genuine resistance burden, differences in who is tested, or both.

Why invasive-isolate surveillance matters

Invasive isolates are usually obtained from normally sterile body sites such as blood. They therefore represent serious infections rather than every community cough, sore throat or urinary symptom. Monitoring these samples helps hospitals and public-health authorities see whether important bacteria are becoming less susceptible to the medicines clinicians rely on.

Surveillance supports several decisions: updating treatment guidance, strengthening infection prevention, targeting laboratory resources and measuring whether stewardship programmes are working. It is a population-level tool, not a test that can choose treatment for an individual patient.

What patients should take from it

  • Antibiotics do not treat viral infections. Colds, influenza and most uncomplicated viral respiratory infections do not improve with antibiotics.
  • A prescription should be used exactly as directed. Do not share leftover medicine or keep it for a future illness.
  • Testing can matter. For serious infections, cultures and susceptibility testing may help clinicians select a more targeted drug.
  • Prevention reduces antibiotic demand. Vaccination, hand hygiene, safe food handling and infection-control practices all reduce opportunities for resistant organisms to spread.

Three limits to remember

First, surveillance data are delayed because laboratories need time to validate and aggregate results. Second, resistance varies by organism, medicine, infection type and local setting; a Europe-wide figure does not replace local guidance. Third, association is not the same as an explanation. The data reveal patterns, but separate research is needed to understand the contribution of prescribing, transmission, health-system access and environmental factors.

The practical message

Antimicrobial resistance is not a reason to avoid antibiotics when they are medically indicated. It is a reason to use them precisely—only when needed, in the right dose and for the prescribed duration—while improving diagnostics and preventing infections. The surveillance update gives health systems a shared evidence base, but responsible decisions still happen locally, between patients, clinicians, pharmacists, laboratories and public-health teams.

Primary source: ECDC and WHO Europe, Surveillance of antimicrobial resistance in Europe, 2025 data, published 18 November 2026.

Sign up to our
weekly newsletter

    More Articles

    - Advertisement -spot_img

    Endocrine-Disrupting Chemicals: What the 2026 Global Evidence Update Actually Says

    A careful guide to the first major UNEP–WHO global update since 2012: what the evidence says about early exposure, health effects, testing gaps and prevention.

    Health Information Online: Five Checks Before You Trust or Share It

    WHO’s new science-and-health initiative highlights trust and clear communication. Five practical checks can help readers assess health claims before acting or sharing.